Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MULTIPLE SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Large-scale testing (Phase 3)Study completedNCT01610687
What this trial is testing

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Who this might be right for
Multiple SclerosisSpasticity
Jazz Pharmaceuticals 137
Not applicableStudy completedNCT06167447
What this trial is testing

Evaluation of the Presence and Effects of Kinesiophobia in Multiple Sclerosis

Who this might be right for
Multiple SclerosisKinesiophobia
Gazi University 90
Not applicableStudy completedNCT05165238
What this trial is testing

Impact Program for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of Alabama at Birmingham 30
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Not applicableStudy completedNCT05787704
What this trial is testing

Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis

Who this might be right for
Multiple SclerosisGait Disorders, NeurologicNeuro-Degenerative Disease+1 more
Karolinska Institutet 41
Early research (Phase 1)Study completedNCT02474134
What this trial is testing

Comparison Study of PF530 and Betaferon in Healthy Subjects

Who this might be right for
Multiple Sclerosis
Pfenex, Inc 12
Large-scale testing (Phase 3)Study completedNCT05323734
What this trial is testing

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Who this might be right for
Tuberous Sclerosis Complex
Marinus Pharmaceuticals 129
Testing effectiveness (Phase 2)Study completedNCT00273364
What this trial is testing

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study

Who this might be right for
Multiple Sclerosis
Northwestern University 110
Not applicableStudy completedNCT01663649
What this trial is testing

Effectiveness of Web-based Treatment for Depression in Patients With Neurologic Disorders

Who this might be right for
Depression
Universitätsklinikum Hamburg-Eppendorf 180
Not applicableUnknownNCT04112537
What this trial is testing

Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic Mutation Relationship

Who this might be right for
Tuberous Sclerosis Complex
University Hospital, Montpellier 90
Not applicableStudy completedNCT06702137
What this trial is testing

EXOPULSE Mollii Suit, Motor Function & Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Institut De La Colonne Vertebrale Et Des Neurosciences 34
Not applicableStudy completedNCT04929145
What this trial is testing

The Gut Microbiome in Adult Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National MS Center Melsbroek 152
Not applicableUnknownNCT06143930
What this trial is testing

Blood Flow Restriction Training in Multiple Sclerosis

Who this might be right for
MS
Cairo University 48
Testing effectiveness (Phase 2)Ended earlyNCT00035529
What this trial is testing

Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bristol-Myers Squibb
Not applicableActive Not RecruitingNCT06699095
What this trial is testing

Home Rehabilitation as Continuity of Care in MS

Who this might be right for
Multiple Sclerosis
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 20
Not applicableStudy completedNCT02950454
What this trial is testing

The Effect of High Intensity Interval Training on Cardiovascular Fitness in People With Progressive Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Progressive
University of Glasgow 12
Testing effectiveness (Phase 2)Study completedNCT00529581
What this trial is testing

C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis

Who this might be right for
Cognition DisordersMultiple Sclerosis
Cognition Pharmaceuticals, LLC 150
Not applicableStudy completedNCT02880553
What this trial is testing

Disability, Perceived Social Support and Quality of Life in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Fondation Ophtalmologique Adolphe de Rothschild 150
Not applicableStudy completedNCT01417312
What this trial is testing

Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Charite University, Berlin, Germany 20
Next Page